Community Research and Development Information Service - CORDIS

FP6

Today's Research for Tomorrow's Treatments, Cell Factory research projects with clinical relevance, EUR 20802

Funded under: FP6-LIFESCIHEALTH

Abstract

Since the market authorisation of the first biotechnologically produced medicine in 1982, biotechnology research is a key element in the development of new diagnostic tools, new therapeutic substances and strategies. The European Commission has supported biotechnology research for more than a decade and this has lead to the establishment of collaborative links among European groups, particularly between academia and industry.
In this publication, an excerpt of projects funded in the 'Cell Factory' sub-area 'Improving the diagnostic and therapeutic arsenal for healthcare' is presented, focussing on those projects, which aim at or include clinical studies, thus being at the forefront of medical applications derived from biotechnological breakthroughs.
Totally, this sub-area comprises 98 projects with a budget of 185.5 Mio ¿, involving 733 scientific and industrial participants, with 97 of them falling into the EC scheme of Small and Medium-Sized Enterprises.
The health problems addressed range from cancer over microbial resistance to neuro-degenerative disorders and organ transplantation. The techniques used and developed are as broad, including gene transfer methods and stem cell techniques. Consequently, the projects outlined here target different pathologies, too, and give an insight into certain biotechnology applications for European healthcare.

Download application/pdf (704509)

Record Number: 7148 / Last updated on: 2005-12-05
Category: STUD